Patient-derived Organoid Pharmacotyping As A Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma.
Sign Up to like & getrecommendations! Published in 2024 at "Annals of surgery"
DOI: 10.1097/sla.0000000000006517
Abstract: OBJECTIVE We integrate a new approach to chemosensitivity data for clinically-relevant regimen matching, and demonstrate the relationship with clinical outcomes in a large PDO biobank. SUMMARY BACKGROUND DATA Pancreatic ductal adenocarcinoma (PDAC) usually recurs following… read more here.
Keywords: ductal adenocarcinoma; patient derived; well matched; poorly matched ... See more keywords